Key Developments: Concord Medical Services Holdings Ltd (CCM)
4.11USD
24 May 2013
$-0.04 (-0.96%)
$4.15
$4.12
$4.19
$4.11
6,410
15,185
$5.09
$2.54
Latest Key Developments (Source: Significant Developments)
Concord Medical Services Holdings Ltd Reaffirms FY 2013 Revenue Guidance
Concord Medical Services Holdings Ltd announced that for fiscal 2013, it expects to generate total net revenues in an estimated range of RMB930 million to RMB975 million. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of CNY934 million for fiscal 2013. Full Article
Concord Medical Services Holdings Ltd Announces Signing Of USD50 Million IFC Loan Agreement
Concord Medical Services Holdings Ltd announced that the Company has signed a USD50 million loan package agreement with IFC (International Financial Corporation), the member of the World Bank Group focused on private sector development in emerging markets. The loan package consists of 1) a $30 million 8-year loan with a variable interest rate of Libor + 4.5%, and 2) a $20 million 5-year convertible bond with a variable interest rate of Libor +3.75% and a conversion price of $6.90 per ADS. The convertible bonds can be converted at lender's discretion, in whole or in part during the term of the loan. Disbursement of the loan proceeds to Concord is subject to various conditions. Subject to satisfaction of these conditions and disbursement of the loan proceeds, the Company will use IFC's $50 million loan for the development of 50 new radiotherapy centers over the next 3 years at county level and the development of a proton beam therapy hospital in Beijing and an oncology hospital in Guangzhou, Guangdong province. Full Article
Concord Medical Services Holdings Ltd Issues FY 2013 Revenue Guidance
Concord Medical Services Holdings Ltd announced that based on current market and operating conditions, estimated business expansion and forecasted Chang'an Hospital financial results, the Company expects to generate total net revenues in an estimated range of RMB930 million to RMB975 million in fiscal 2013. Full Article
Concord Medical Services Holdings Ltd Issues Q4 2012 Revenue Guidance
Concord Medical Services Holdings Ltd announced that it estimates total net revenues for the fourth quarter of 2012 to be between RMB193 million and RMB210 million, including net revenues from the network business to be between RMB105 million to RMB115 million and net revenues from the hospital business to be between RMB88 million and RMB95 million. Full Article
Concord Medical Services Holdings Ltd Announces Extension Of Existing Share Repurchase Program
Concord Medical Services Holdings Ltd announced that its board of directors has approved the extension of its previously announced share repurchase program, which was set to expire in October 2012. The program was extended until the aggregate value of the Company's repurchases equals $20 million. Full Article
Concord Medical Services Holdings Ltd Signs Framework Agreement To Establish Cancer Specialty Hospital In Beijing International Medical Center
Concord Medical Services Holdings Limited announced that it has signed a framework agreement with Beijing International Medical Center (BIMC) to establish a cancer specialty hospital. Under the agreement, the hospital will be wholly owned by Concord Medical and provide comprehensive cancer therapies, including surgery, chemotherapy, radiotherapy and gene therapy, to high-end cancer patients. Concord Medical will provide management support, treatment, technology and research to the hospital, including protocols and clinical practice guidelines, by collaborating with top-notch cancer institutions around the world. Concord Medical plans to begin designing of the hospital and other early-stage works soon. Full Article
Concord Medical Services Holdings Ltd's Chang'an Hospital And Fox Chase Cancer Center Sign Strategic Alliance Agreement
Concord Medical Services Holdings Limited announced that its subsidiary Chang'an Hospital has signed a strategic alliance agreement with Fox Chase Cancer Center (FCCC). Under the agreement, Fox Chase Cancer Center will provide support of management, treatment, technology and research to Chang'an Hospital, including protocols and clinical practice guidelines on cancer surgery, chemotherapy, radiotherapy, gene therapy and prevention. In particular, FCCC will send clinical and management experts to Chang'an Hospital to practice, give lectures and inspect annual quality control standards. At the same time, FCCC will accept management and technical personnel from Chang'an Hospital to study and train there. In addition, FCCC will provide remote diagnosis and treatment programs to Chang'an Hospital. The two organizations will jointly conduct cancer clinical and fundamental research, and share information and research results. Full Article
Concord Medical Services Holdings Ltd Announces Closing Of Acquisition Of 52% Ownership In Chang'an Hospital
Concord Medical Services Holdings Ltd announced that it has closed the acquisition of 52% equity ownership in Chang'an Hospital, a non-public general hospital located in Xi'an, Shaanxi Province. The company announced the signing of a definite agreement in connection with the acquisition of 52% equity ownership in Chang'an Hospital on March 22, 2012. Full Article
Concord Medical Services Holdings Ltd Raises FY 2012 Revenue Guidance
Concord Medical Services Holdings Ltd announced that for fiscal 2012, it expects net revenues of RMB590-RMB630 million. Full Article
Concord Medical Services Holdings Ltd Issues FY 2012 Revenue Guidance
Concord Medical Services Holdings Ltd announced that for fiscal 2012, it expects net revenues to be in the range of RMB590-RMB630 million. Full Article
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
